Technical Analysis for RGC - Regencell Bioscience Holdings Limited
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 5.35 | 4.90% | 0.25 |
RGC closed up 4.9 percent on Thursday, April 25, 2024, on 23 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 50 DMA | Bullish | 0.00% | |
| 180 Bullish Setup | Bullish Swing Setup | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Fell Below 50 DMA | Bearish | 4.90% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 4.90% | |
| New Uptrend | Bullish | 4.90% | |
| Calm After Storm | Range Contraction | 4.90% |
| Alert | Time |
|---|---|
| Possible NR7 | 1 day ago |
| Rose Above 50 DMA | 1 day ago |
| 1.5x Volume Pace | 1 day ago |
| Up 3% | 1 day ago |
| Up 2% | 1 day ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Regencell Bioscience Holdings Limited operates a traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Neuroscience Psychiatric Diagnosis Psychiatry Attention Deficit Hyperactivity Disorder Autism Spectrum Disorder Traditional Chinese Medicine Autism Learning Disabilities Causeway Bay Neurocognition
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Neuroscience Psychiatric Diagnosis Psychiatry Attention Deficit Hyperactivity Disorder Autism Spectrum Disorder Traditional Chinese Medicine Autism Learning Disabilities Causeway Bay Neurocognition
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 31.3 |
| 52 Week Low | 3.16 |
| Average Volume | 5,071 |
| 200-Day Moving Average | 12.76 |
| 50-Day Moving Average | 5.26 |
| 20-Day Moving Average | 4.42 |
| 10-Day Moving Average | 4.93 |
| Average True Range | 0.76 |
| RSI (14) | 55.56 |
| ADX | 30.19 |
| +DI | 48.67 |
| -DI | 10.66 |
| Chandelier Exit (Long, 3 ATRs) | 6.31 |
| Chandelier Exit (Short, 3 ATRs) | 5.45 |
| Upper Bollinger Bands | 6.07 |
| Lower Bollinger Band | 2.77 |
| Percent B (%b) | 0.78 |
| BandWidth | 74.59 |
| MACD Line | 0.15 |
| MACD Signal Line | -0.12 |
| MACD Histogram | 0.2673 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.88 | ||||
| Resistance 3 (R3) | 5.82 | 5.58 | 5.79 | ||
| Resistance 2 (R2) | 5.58 | 5.45 | 5.61 | 5.76 | |
| Resistance 1 (R1) | 5.47 | 5.37 | 5.53 | 5.53 | 5.73 |
| Pivot Point | 5.23 | 5.23 | 5.26 | 5.26 | 5.23 |
| Support 1 (S1) | 5.12 | 5.10 | 5.18 | 5.18 | 4.97 |
| Support 2 (S2) | 4.88 | 5.02 | 4.91 | 4.94 | |
| Support 3 (S3) | 4.77 | 4.88 | 4.91 | ||
| Support 4 (S4) | 4.83 |
